Last $0.02 USD
Change Today -0.0007 / -3.52%
Volume 502.1K
As of 8:10 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

oxis international inc (OXIS) Snapshot

Open
$0.02
Previous Close
$0.02
Day High
$0.02
Day Low
$0.01
52 Week High
07/11/14 - $0.03
52 Week Low
12/9/13 - $0.0030
Market Cap
11.4M
Average Volume 10 Days
405.5K
EPS TTM
$-0.02
Shares Outstanding
591.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for OXIS INTERNATIONAL INC (OXIS)

Related News

No related news articles were found.

oxis international inc (OXIS) Related Businessweek News

No Related Businessweek News Found

oxis international inc (OXIS) Details

Oxis International, Inc. engages in the research, development, and sale of pharmaceutical products for the treatment of oxidative stress and inflammation. Its finished product and finished product candidates include therapeutic nutraceutical products, cosmeceutical products, functionals foods, and functional beverages. The company also provides proprietary compounds and formulations to biotech and pharmaceutical companies as drug candidates; EGT, a dietary supplement; and ErgoFlex, dietary supplement for the treatment of joint pain and restricted mobility. In addition, it offers personal care products, including skin care and cosmetic products; and veterinary products for companion animals, livestock, and performance animals, such as race horses. The company owns a range of trademarks, including ErgoFlex, Ergo-Plex, ERGOLD, Ergo-Max, Ergo-Pur, V[eye]tamin, and Immortal Energy, as well as a non-EGT related trademark Palosein. Oxis International, Inc. was founded in 1965 and is based in Beverly Hills, California.

oxis international inc (OXIS) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

oxis international inc (OXIS) Key Developments

OXIS International Inc. Appoints Steven Weldon as a Board of Directors, Chief Financial Officer and Chief Accounting Officer

OXIS International Inc. announced that on September 29, 2014, Steven Weldon was elected a member of the Board of Directors of the company and on November 3, 2014, was appointed the Chief Financial Officer and Chief Accounting Officer of the company. Mr. Weldon is a certified public accountant and is licensed to practice in the state of Florida. Mr. Weldon, has over 15 years of financial and accounting experience with public and private companies. Mr. Weldon was appointed as Chief Financial Officer and as a member of the board of directors of Growblox Sciences Inc., a Delaware corporation in September 2005 and serves in both positions currently. Mr. Weldon also served as chief executive officer of Growblox Sciences from December 29, 2009, through May 2, 2011, and from April 18, 2012, through March 13, 2014.

OXIS International Inc. Announces Board of Directors Changes

OXIS International Inc. announced effective as of July 25, 2014, Anshuman Dube and David Saloff resigned from their respective positions as members of the Board of Directors. Also effective as of July 25, 2014, Anthony Cataldo was appointed to the Board as a new director to fill one of the vacancies created by the aforementioned resignation of the two directors. Mr. Cataldo will serve as the Chairman of the Board of Directors. Mr. Cataldo previously served as a director and as the company’s Chief Executive Officer from March 2009 to August 2011.

OXIS International Seeks Acquisitions

OXIS International Inc. (OTCPK:OXIS) received $1.25 million in cash from the offering of the securities. The net proceeds of the offering, approximately $1.2 million, will be used by OXIS to fund the costs of filing all of delinquent Securities and Exchange Commission reports, increase the marketing of therapeutic nutraceutical products, and investigate one or more possible strategic acquisitions of businesses in the nutraceutical or medical product markets, including the medical marijuana industry. OXIS has not entered into any agreements for any such strategic acquisitions, and no assurance can be given that OXIS will make any future acquisition.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OXIS:US $0.02 USD -0.0007

OXIS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OXIS.
View Industry Companies
 

Industry Analysis

OXIS

Industry Average

Valuation OXIS Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OXIS INTERNATIONAL INC, please visit www.oxis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.